ACE2 and COVID-19: The clinical course of the disease has been challenged by the interaction of three genetic polymorphisms, all affected by COVID-19: first is the CYP2D6 enzyme system, second is the HO-1 anti-inflammatory gene, and third the ACE and ACE-2 enzyme systems.